NASDAQ:ANAC - Anacor Pharmaceuticals Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $99.20 0.00 (0.00 %) (As of 07/16/2018 04:00 PM ET)Previous Close$99.20Today's Range$99.20 - $99.2052-Week Range$52.00 - $156.93VolumeN/AAverage Volume1.81 million shsMarket Capitalization$4.50 billionP/E RatioN/ADividend YieldN/ABeta1.53 Company ProfileFinancialsEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Anacor Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing small-molecule therapeutics derived from its boron chemistry platform. Its lead product development candidate is crisaborole topical ointment, approximately 2%, a non-steroidal topical anti-inflammatory phosphodiesterase-4 (PDE-4) inhibitor in development for the treatment of mild-to-moderate atopic dermatitis and psoriasis. Its product, KERYDIN (tavaborole) topical solution, approximately 5%, is an oxaborole antifungal approved by the United States Food and Drug Administration (FDA) for the topical treatment of onychomycosis of the toenails. It also has a pipeline of other internally discovered topical and systemic boron-based compounds in early-stages of research and development, which include AN3365. Its compound, AN5568 (SCYX-7158), is licensed to Drugs for Neglected Diseases initiative (DNDi) for the treatment of human African trypanosomiasis. Receive ANAC News and Ratings via Email Sign-up to receive the latest news and ratings for ANAC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryBiotechnology SectorN/A SymbolNASDAQ:ANAC CUSIP03242010 Webwww.anacor.com Phone+1-650-5437500 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins-92.08% Return on Equity-133.71% Return on Assets-38.09% Miscellaneous EmployeesN/A Outstanding Shares44,860,000Market Cap$4,500.00 Anacor Pharmaceuticals (NASDAQ:ANAC) Frequently Asked Questions What is Anacor Pharmaceuticals' stock symbol? Anacor Pharmaceuticals trades on the NASDAQ under the ticker symbol "ANAC." How were Anacor Pharmaceuticals' earnings last quarter? Anacor Pharmaceuticals Inc (NASDAQ:ANAC) issued its quarterly earnings results on Tuesday, May, 10th. The biopharmaceutical company reported ($0.36) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.35) by $0.01. The biopharmaceutical company had revenue of $17.54 million for the quarter, compared to the consensus estimate of $19.53 million. Anacor Pharmaceuticals had a negative return on equity of 133.71% and a negative net margin of 92.08%. The company's revenue for the quarter was up 14.9% on a year-over-year basis. During the same period last year, the firm earned ($0.30) EPS. View Anacor Pharmaceuticals' Earnings History. What is the consensus analysts' recommendation for Anacor Pharmaceuticals? 0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Anacor Pharmaceuticals in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A." Has Anacor Pharmaceuticals been receiving favorable news coverage? News coverage about ANAC stock has been trending somewhat negative recently, according to Accern. The research group ranks the sentiment of press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Anacor Pharmaceuticals earned a news sentiment score of 0.00 on Accern's scale. They also assigned media stories about the biopharmaceutical company an impact score of 44.27 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future. How do I buy shares of Anacor Pharmaceuticals? Shares of ANAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Anacor Pharmaceuticals' stock price today? One share of ANAC stock can currently be purchased for approximately $99.20. How big of a company is Anacor Pharmaceuticals? Anacor Pharmaceuticals has a market capitalization of $4.50 billion. How can I contact Anacor Pharmaceuticals? Anacor Pharmaceuticals' mailing address is 1020 E Meadow Cir, PALO ALTO, CA 94303-4230, United States. The biopharmaceutical company can be reached via phone at +1-650-5437500. MarketBeat Community Rating for Anacor Pharmaceuticals (NASDAQ ANAC)Community Ranking: 3.4 out of 5 ( )Outperform Votes: 260 (Vote Outperform)Underperform Votes: 125 (Vote Underperform)Total Votes: 385MarketBeat's community ratings are surveys of what our community members think about Anacor Pharmaceuticals and other stocks. Vote "Outperform" if you believe ANAC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ANAC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/16/2018 by MarketBeat.com StaffFeatured Article: What does RSI mean?